These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21789443)

  • 1. [Foreword. Brazilian clinical practice guidelines for mineral and bone disorders in chronic renal disease].
    de Carvalho AB
    J Bras Nefrol; 2011; 33(2):191. PubMed ID: 21789443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

  • 3. [The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)].
    Drüeke TB
    Nephrol Ther; 2010 Jun; 6(3):149-50. PubMed ID: 20188646
    [No Abstract]   [Full Text] [Related]  

  • 4. KDIGO CKD-MBD Discussion forum: the Brazilian perspective.
    Moysés RM; Cancela AL; Gueiros JE; Barreto FC; Neves CL; Canziani ME; Oliveira RB; Jorgetti V; Carvalho AB
    J Bras Nefrol; 2010; 32(3):229-36. PubMed ID: 21103684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
    Limardo M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
    [No Abstract]   [Full Text] [Related]  

  • 6. FGF23: a key player in mineral and bone disorder in CKD.
    Komaba H; Fukagawa M
    Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
    National Kidney Foundation
    Am J Kidney Dis; 2003 Oct; 42(4 Suppl 3):S1-201. PubMed ID: 14520607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Brazilian guidelines for bone and mineral disorders in CKD children].
    Lima EM; Gesteira Mde F; Bandeira Mde F;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():42-57. PubMed ID: 21655859
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction.
    Torregrosa JV; Bover J; Cannata Andía J
    Nefrologia; 2011; 31 Suppl 1():1-2. PubMed ID: 21468160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey].
    Bover J; Górriz JL; Martín de Francisco AL; Caravaca F; Barril G; Molinero LM;
    Nefrologia; 2008; 28(6):637-43. PubMed ID: 19016638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for mineral and bone disorder in chronic kidney disease].
    Staszków M; Przedlacki J
    Wiad Lek; 2014; 67(3):422-5. PubMed ID: 25782204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From renal osteodistrophy to bone and mineral metabolism lesions associated to renal chronic disease].
    Lorenzo V; Rodríguez Portillo M; Pérez García R; Cannata JB
    Nefrologia; 2007; 27(5):527-33. PubMed ID: 18045027
    [No Abstract]   [Full Text] [Related]  

  • 14. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All research does not a guideline make!
    Moorthi RN; Moe SM; Drüeke T; Uhlig K
    Am J Kidney Dis; 2010 Apr; 55(4):631-4. PubMed ID: 20338464
    [No Abstract]   [Full Text] [Related]  

  • 16. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
    Lebner AC; Beard KM; Soroka SD; Cournoyer SH; Da Roza GA; Geary DF; Mendelssohn DC
    Nephrol Dial Transplant; 2011 Jan; 26(1):156-63. PubMed ID: 20667990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS.
    Tentori F
    Semin Dial; 2010; 23(1):10-4. PubMed ID: 20331811
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
    López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
    Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral metabolism.
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):B113-8. PubMed ID: 9263694
    [No Abstract]   [Full Text] [Related]  

  • 20. [The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)].
    Jean G; Chazot C
    Nephrol Ther; 2010 Jun; 6(3):151-7. PubMed ID: 20399169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.